Dec 17, 2024 04:05PM
Aug 6, 2024 07:00AM
Mar 12, 2024 08:06AM
Mar 12, 2024 08:00AM
Feb 22, 2024 07:00AM
Dec 12, 2023 09:03AM
Dec 12, 2023 09:00AM NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)
Dec 5, 2023 09:01AM
Dec 5, 2023 09:00AM
Oct 26, 2023 07:00AM
Jul 27, 2023 07:00AM
Jul 11, 2023 09:03AM
Jul 11, 2023 09:00AM
Jun 28, 2023 09:00AM Recent Publications Demonstrate Utility of DPNCheck® for Identifying High-Risk Diabetes Patients
Jun 7, 2023 09:00AM
May 31, 2023 09:01AM
May 31, 2023 09:00AM
Apr 28, 2023 09:21AM
Mar 21, 2023 09:00AM
Feb 23, 2023 07:00AM
Feb 16, 2023 02:58PM NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2022 Financial Results Conference Call
Jan 23, 2023 09:04AM
Jan 23, 2023 09:00AM
Nov 8, 2022 09:00AM
Nov 3, 2022 09:05AM
Nov 3, 2022 09:00AM
Oct 20, 2022 07:00AM
Oct 12, 2022 03:47PM NeuroMetrix, Inc. Announces Date for Third Quarter 2022 Financial Results Conference Call
Sep 1, 2022 09:00AM
Jul 21, 2022 07:00AM
May 19, 2022 09:00AM
Apr 26, 2022 07:00AM
Feb 24, 2022 09:00AM
Jan 27, 2022 07:00AM
Jan 18, 2022 09:30AM Pre-Open Stock Movers 01/18: (ATVI) (BBI) (NURO) Higher; (RMED) (GPS) (GS) Lower (more...)
Jan 18, 2022 09:01AM
Jan 18, 2022 09:00AM
Oct 21, 2021 07:00AM
Oct 7, 2021 05:35AM
Oct 6, 2021 06:42PM
Jul 26, 2021 09:06AM
Jul 26, 2021 09:00AM NeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of Fibromyalgia
Jul 22, 2021 07:00AM
Jul 20, 2021 09:25AM
Jul 20, 2021 09:00AM
Jul 20, 2021 09:00AM
Jun 9, 2021 08:00AM
Oct 22, 2020 07:00AM
Oct 15, 2020 11:00AM NeuroMetrix, Inc. Announces Date for Third Quarter 2020 Financial Results Conference Call
Sep 22, 2020 07:00AM

322,873 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All